Neurotrack’s highly accurate and time-saving digital tools standardize testing and close gaps in MCI and dementia detection. Timely diagnosis improves patient outcomes and access to care.
90%
of staff say Neurotrack's screener is easy to use
9/10
providers prefer Neurotrack to traditional tests
15K+
providers can administer Neurotrack's cognitive screening
10 mins
or more saved per patient by switching to Neurotrack
375+ peer-reviewed publications, 25 core studies, and funding from leaders like the NIA and the Gates Foundation.
90% find our screening easy to use (and prefer it to traditional tests like Mini-Cog, MMSE, and SLUMs).
Neurotrack's ranks are growing. 15,000+ clinicians across leading health systems, home health, and primary care use our solutions.
FDA-registered. Works on any device. Integrates with all EHRs. SOC 2- and HIPAA-compliant. Deploys in weeks, not months.
This entrepreneur aims to make cognitive screening as easy as checking your pulse.
Alex Knapp, Staff Writer
Did you know 80% of 65-80 year olds aren't getting routine screening? Underdetection is a crisis.
Neurotrack powers a screening program that's closing gaps and connecting patients to care.
Neurotrack CEO Elli Kaplan explains how in-home evaluations are helping the cause
The 7 key takeaways of 2024's news on neurocognitive disease.
Cognitive screening refers to brief, structured evaluation of mental functions including memory, attention, and executive function. It enables early detection of conditions like mild cognitive impairment and dementia—critical for improving patient outcomes, reducing downstream costs, and aligning with value-based care models.